Mercer Global Advisors
SRNE

Mercer Global Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mercer Global Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,717
Closed -$60K – 1283
2019
Q4 		$60K Buy
17,717
+738
+4% +$1.76K ﹤0.01% 1140
2019
Q3 		$36K Sell
16,979
-1,325
-7% -$3.09K ﹤0.01% 1109
2019
Q2 		$49K Buy
18,304
+2,250
+14% +$8.1K ﹤0.01% 1123
2019
Q1 		$76K Buy
+16,054
New +$42.1K ﹤0.01% 1033

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return